Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.

Saved in:

Bibliographic Details
Title:	Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
Authors:	Brandberg, Yvonne¹, Johansson, Hemming¹, Aamdal, Steinar², Bastholt, Lars³, Hernberg, Michaela⁴, Stierner, Ulrika⁵, von der Maase, Hans^6,7, Hansson, Johan¹
Source:	Acta Oncologica. Aug2013, Vol. 52 Issue 6, p1086-1093. 8p. 5 Charts, 1 Graph.
Database:	Academic Search Ultimate

Description
ISSN:	0284186X
DOI:	10.3109/0284186X.2013.789140